Cargando…

Identification of serious, unpredictable adverse events with tocilizumab

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366479/
http://dx.doi.org/10.1007/s40278-020-80763-1
_version_ 1783560231154876416
collection PubMed
description
format Online
Article
Text
id pubmed-7366479
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73664792020-07-17 Identification of serious, unpredictable adverse events with tocilizumab Reactions Weekly Clinical Study Springer International Publishing 2020-07-18 2020 /pmc/articles/PMC7366479/ http://dx.doi.org/10.1007/s40278-020-80763-1 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Identification of serious, unpredictable adverse events with tocilizumab
title Identification of serious, unpredictable adverse events with tocilizumab
title_full Identification of serious, unpredictable adverse events with tocilizumab
title_fullStr Identification of serious, unpredictable adverse events with tocilizumab
title_full_unstemmed Identification of serious, unpredictable adverse events with tocilizumab
title_short Identification of serious, unpredictable adverse events with tocilizumab
title_sort identification of serious, unpredictable adverse events with tocilizumab
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366479/
http://dx.doi.org/10.1007/s40278-020-80763-1